Viking Therapeutics has multiple promising drugs in its portfolio that could generate billions in future revenue. Approval of VK2735 and VK2809 could lead to a surge in the stock's value. There is ...

Viking Therapeutics has two exciting pipeline candidates. The biotech could deliver excellent returns in the next five years if these programs perform well. There are also some risks to consider for ...

A new passenger-car ferry powered entirely by battery power could support the launch of a green corridor across the Gulf of Finland. It's not going to happen fast, and it requires a team effort ...

The pharmaceutical and biotechnology business tends to be about hitting home runs more than just getting on base. A highly successful drug, sometimes referred to as a blockbuster, can build up a small ...

Viking has canceled Egypt river cruises through March due to Middle East conflict, prioritizing guest safety and adhering to U.S. State Department guidance, but remains optimistic about minimal ...

The Viking Brahmaputra wil have Viking's signature Scandinavian design. Photo Credit: Viking Viking will offer its first river cruises in India beginning in 2027, debuting the itineraries after seeing ...

Straight out of a “Thor” movie plot, the Viking calendar has predicted that the world will end on Saturday. Ragnarök, or The Twilight of the Gods, is upon us, if recent weather is to be believed, USA ...

Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects. This year, ...